Anna Simon

14.0k citations

130 papers · 7.3k indexed · 3 hit papers · h-index 36

Impact in

Immunology top 0.5%
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- interferon and immune responses
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Immunology 55
- Immune Cell Function and Interaction 15
- IL-33, ST2, and ILC Pathways 15
Nephrology 18
- Gout, Hyperuricemia, Uric Acid 10

Co-authors: Jos W.M. van der Meer (19 shared papers)Charles A. Dinarello (1 shared paper)Daniel L. Kastner (3 shared papers)Joost P.H. Drenth (20 shared papers)Ivona Aksentijevich (1 shared paper)Seth L. Masters (1 shared paper)Jeroen C.H. van der Hilst (11 shared papers)J.W.M. van der Meer (10 shared papers)
Journals: Annals of the Rheumatic Diseases (10 papers)Pediatric Rheumatology (7 papers)Lara D. Veeken (7 papers)Allergy (3 papers)Clinical and Experimental Rheumatology (2 papers)
Partner nations: Netherlands United States France

In The Last Decade

Anna Simon

122 papers receiving 7.1k citations

Hit Papers

align trajectories log scale

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases 2012 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Nature Reviews Drug Discovery
2011 The Journal of Experimental Medicine
2009 Annual Review of Immunology

Peers

Countries citing papers authored by Anna Simon

Since Specialization

Citations

This map shows the geographic impact of Anna Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Simon more than expected).

Fields of papers citing papers by Anna Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Simon. The network helps show where Anna Simon may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Simon Line = papers co-authored together Anna Simon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nature Reviews Drug Discovery ·Charles A. Dinarello, Anna Simon, Jos W.M. van der Meer Hit paper breakdown →	2012	1349
2	Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease Annual Review of Immunology ·Seth L. Masters, Anna Simon, Ivona Aksentijevich, Daniel L. Kastner Hit paper breakdown →	2009	796
3	Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS) The Journal of Experimental Medicine ·Ariel C. Bulua, Anna Simon, Ravikanth Maddipati, Martin Pelletier, Heiyoung Park, Kye-Young Kim, Michael N. Sack, Daniel L. Kastner, Richard M. Siegel Hit paper breakdown →	2011	695
4	IL-1β Processing in Host Defense: Beyond the Inflammasomes PLoS Pathogens ·Mihai G. Netea, Anna Simon, Frank L. van de Veerdonk, Bart Jan Kullberg, Jos W.M. van der Meer, Leo A. B. Joosten	2010	417
5	Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. PubMed ·Gary S. Francis, Jay N. Cohn, GJ Johnson, Tom S. Rector, Steven Goldman, Anna Simon	1993	291
6	Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome Medicine ·Jeroen C.H. van der Hilst, Evelien J. Bodar, Karyl S. Barron, Joost Frenkel, Joost P.H. Drenth, J.W.M. van der Meer, Anna Simon	2008	245
7	Schnitzler's syndrome: diagnosis, treatment, and follow‐up Allergy ·Anna Simon, Bouchra Asli, Markus Braun‐Falco, Heleen D. de Koning, Jean‐Paul Fermand, C Grattan, Karoline Krause, Helen J. Lachmann, C. Lenormand, V. Martínez-Taboada, Marcus Maurer, Margot S. Peters, Rita Rizzi, Franco Rongioletti, Thomas Ruzicka, L Schnitzler, B Schubert, Jean Sibilia, Dan Lipsker	2013	166
8	Schnitzler Syndrome: Beyond the Case Reports: Review and Follow-Up of 94 Patients with an Emphasis on Prognosis and Treatment Seminars in Arthritis and Rheumatism ·Heleen D. de Koning, Evelien J. Bodar, Jos W.M. van der Meer, Anna Simon	2007	159
9	Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome Clinical Pharmacology & Therapeutics ·Anna Simon	2004	144
10	Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome European Journal of Human Genetics ·(unknown), Laurence Cuisset, Joost P.H. Drenth, Anna Simon, Marie Françoise Vincent, Saskia van der Velde Visser, J W van der Meer, Gilles Grateau, Marc Delpech	2001	140
11	Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome Proceedings of the National Academy of Sciences ·Anna Simon, Heiyoung Park, Ravikanth Maddipati, Adrian A. Lobito, Ariel C. Bulua, Adrianna J. Jackson, Jae Jin Chae, Rachel Ettinger, Heleen D. de Koning, Anthony Cruz, Daniel L. Kastner, Hirsh D. Komarow, Richard M. Siegel	2010	130
12	Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. PubMed ·E.J. Bodar, Jeroen C.H. van der Hilst, Joost P.H. Drenth, J.W.M. van der Meer, Anna Simon	2005	130
13	On-demand anakinra treatment is effective in mevalonate kinase deficiency Annals of the Rheumatic Diseases ·E.J. Bodar, Loes M. Kuijk, Joost P.H. Drenth, J.W.M. van der Meer, Anna Simon, Joost Frenkel	2011	114
14	Mevalonate kinase deficiency Neurology ·Anna Simon, H.P.H. Kremer, Ron A. Wevers, Hans Scheffer, J.G. de Jong, J.W.M. van der Meer, Joost P.H. Drenth	2004	100
15	Hereditary periodic fever and reactive amyloidosis Clinical and Experimental Medicine ·Jeroen C.H. van der Hilst, Anna Simon, Joost P.H. Drenth	2005	93
16	Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Anna Simon, Jos W.M. van der Meer	2006	93
17	Validation of the Auto-Inflammatory Diseases Activity Index (AIDAI) for hereditary recurrent fever syndromes Annals of the Rheumatic Diseases ·Maryam Piram, Isabelle Koné‐Paut, Helen J. Lachmann, Joost Frenkel, Seza Özen, Jasmin Kuemmerle‐Deschner, S Stojanov, Anna Simon, Martina Finetti, Maria Pia Sormani, Alberto Martini, Marco Gattorno, Nicolino Ruperto	2013	91
18	International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors Lara D. Veeken ·Taryn Youngstein, Patrycja Hoffmann, Ahmet Gül, Thirusha Lane, René M. Williams, Dorota Rowczenio, Huri Özdoğan, Serdal Uğurlu, John Ryan, Len Harty, Sean Riminton, Alex P. Headley, Joachim Roesler, Norbert Blank, Jasmin Kuemmerle‐Deschner, Anna Simon, Adrian S. Woolf, Philip N. Hawkins, Helen J. Lachmann	2017	88
19	A high-performance multiple-reflection time-of-flight mass spectrometer and isobar separator for the research with exotic nuclei Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment ·T. Dickel, W. R. Plaß, Anna Becker, U. Czok, H. Geißel, E. Haettner, C. Jesch, Wadim Kinsel, Martin Petrick, C. Scheidenberger, Anna Simon, Mikhail Yavor	2015	81
20	MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease Annals of the Rheumatic Diseases ·Monique Stoffels, Agata Szperl, Anna Simon, Mihai G. Netea, Theo S. Plantinga, Marcel van Deuren, Sylvia Kamphuis, Helen J. Lachmann, Edwin Cuppen, Wigard P. Kloosterman, Joost Frenkel, Cleo C. van Diemen, Cisca Wijmenga, Mariëlle van Gijn, Jos W.M. van der Meer	2013	71

About Anna Simon

Anna Simon is a scholar working on Immunology, Nephrology, Hematology, Emergency Medicine and Molecular Biology, having authored 130 papers that have together received 7.3k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (65 papers), Autoimmune and Inflammatory Disorders Research (22 papers), Immune Cell Function and Interaction (15 papers), IL-33, ST2, and ILC Pathways (15 papers), Cardiovascular Health and Disease Prevention (11 papers), Streptococcal Infections and Treatments (11 papers), Hematological disorders and diagnostics (10 papers) and Gout, Hyperuricemia, Uric Acid (10 papers). The work is most often cited by research in Immunology (3.1k citations), Hematology (1.3k citations), Nephrology (672 citations), Molecular Biology (4.4k citations) and Rheumatology (857 citations). Anna Simon has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Jos W.M. van der Meer, Charles A. Dinarello, Daniel L. Kastner, Joost P.H. Drenth, Ivona Aksentijevich, Seth L. Masters, Jeroen C.H. van der Hilst, J.W.M. van der Meer, Heleen D. de Koning and Evelien J. Bodar. Their work appears in journals such as Annals of the Rheumatic Diseases, Pediatric Rheumatology, Lara D. Veeken, Allergy and Clinical and Experimental Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact